Assessment of necrosis and hypoxia in ductal carcinoma in situ of the breast: basis for a new classification

[1]  J. Gornbein,et al.  Outcomes and factors impacting local recurrence of ductal carcinoma in situ , 2000, Cancer.

[2]  Shoker,et al.  DCIS grading schemes and clinical implications , 1999, Histopathology.

[3]  A. Sabichi,et al.  Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. , 1999, Human pathology.

[4]  P. Brousset,et al.  In vivo patterns of Bcl‐2 family protein expression in breast carcinomas in relation to apoptosis , 1999, The Journal of pathology.

[5]  D A Bloch,et al.  Tissue oxygen distribution in head and neck cancer patients , 1999, Head & neck.

[6]  A. De Benedetti,et al.  Elevated expression of eIF4E in confined early breast cancer lesions: Possible role of hypoxia , 1999, International journal of cancer.

[7]  J. Peterse,et al.  Consistency achieved by 23 european pathologists in categorizing ductal carcinoma in situ of the breast using five classifications , 1998 .

[8]  I. Ellis,et al.  Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up. , 1998, Human pathology.

[9]  A. Giaccia,et al.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. , 1998, Cancer research.

[10]  S. Martino,et al.  Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  F. O'Malley,et al.  Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67. , 1997, Human pathology.

[12]  M. Lagios,et al.  Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis. , 1997, Human pathology.

[13]  B. Wouters,et al.  Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. , 1997, Radiation research.

[14]  R. Mansel,et al.  A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma , 1996, Histopathology.

[15]  M. Silverstein,et al.  A prognostic index for ductal carcinoma in situ of the breast , 1996, Cancer.

[16]  Barbara L. Smith,et al.  Developing a prognostic index for ductal carcinoma in situ of the breast: Are we there yet? , 1996, Cancer.

[17]  S. Schnitt,et al.  Extensive apoptosis in ductal carcinoma in situ of the breast , 1996, Cancer.

[18]  J. Peterse,et al.  Microcalcifications in ductal carcinoma in situ of the breast: histochemical and immunohistochemical study. , 1996, Human pathology.

[19]  M. J. Silverstein,et al.  Prognostic classification of breast ductal carcinoma-in-situ , 1995, The Lancet.

[20]  F. Schmitt,et al.  Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c‐erbB‐2 protein , 1995, Cancer.

[21]  M. Lagios.  Heterogeneity of duct carcinoma in situ (DCIS): relationship of grade and subtype analysis to local recurrence and risk of invasive transformation. , 1995, Cancer letters.

[22]  M. Lagios,et al.  Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast. , 1994, Cancer letters.

[23]  M. J. van de Vijver,et al.  Ductal carcinoma in situ: a proposal for a new classification. , 1994, Seminars in diagnostic pathology.

[24]  W. Gregory,et al.  The classification of ductal carcinoma in situ and its association with biological markers. , 1994, Seminars in diagnostic pathology.

[25]  W. Dupont,et al.  p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[26]  Anthony J. Guidi,et al.  Microvessel density and distribution in ductal carcinoma in situ of the breast. , 1994, Journal of the National Cancer Institute.

[27]  D N Poller,et al.  Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[28]  J. Peterse,et al.  Ductal carcinoma in-situ of the breast; second EORTC consensus meeting. , 1992, European journal of cancer.

[29]  N. Mayr,et al.  Morphometric studies in intraductal breast carcinoma using computerized image analysis , 1991, Cancer.

[30]  P Vaupel,et al.  Evaluation of oxygen diffusion distances in human breast cancer xenografts using tumor-specific in vivo data: role of various mechanisms in the development of tumor hypoxia. , 1988, International journal of radiation oncology, biology, physics.

[31]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[32]  D. Page,et al.  Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions , 1994, Cancer.